| 1 |
Effect of carvedilol against myocardial injury due to ischemia–reperfusion of the brain in rats |
|
| | Meilei Harima,Somasundaram Arumugam,Juan Wen,Vigneshwaran Pitchaimani,Vengadeshprabhu Karuppagounder,Mst. Rejina Afrin,Remya Sreedhar,Shizuka Miyashita,Mayumi Nomoto,Kazuyuki Ueno,Masahiko Nakamura,Kenichi Watanabe | | | Experimental and Molecular Pathology. 2015; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Carvedilol promotes neurological function, reduces bone loss and attenuates cell damage after acute spinal cord injury in rats |
|
| | Da Liu,Ying Huang,Bin Li,Changqing Jia,Feng Liang,Qin Fu | | | Clinical and Experimental Pharmacology and Physiology. 2015; 42(2): 202 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Mitochondrial toxicity of cardiac drugs and its relevance to mitochondrial disorders |
|
| | Josef Finsterer,Sinda Zarrouk-Mahjoub | | | Expert Opinion on Drug Metabolism & Toxicology. 2014; : 1 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
TLR4 signaling: A potential therapeutic target in ischemic coronary artery disease |
|
| | Su-Jie Jia,Pan-Pan Niu,Jun-Zi Cong,Bi-Kui Zhang,Ming Zhao | | | International Immunopharmacology. 2014; 23(1): 54 | | | [Pubmed] [Google Scholar] [DOI] | |
|
